OBJECTIVE: To analyze the extent and spatial distribution of white matter hyperintensities (WMH) in brain regions from cognitively normal older individuals (CN) and patients with mild cognitive impairment (MCI) and Alzheimer disease (AD). METHODS: We studied 26 mild AD, 28 MCI, and 33 CN. MRI analysis included quantification of WMH volume, nonlinear mapping onto a common anatomic image, and spatial localization of each WMH voxel to create an anatomically precise frequency distribution map. Areas of greatest frequency of WMH from the WMH composite map were used to identify 10 anatomic regions involving periventricular areas and the corpus callosum (CC) for group comparisons. RESULTS: Total WMH volumes were associated with age, extent of concurrent vascular risk factors, and diagnosis. After correcting for age, total WMH volumes remained significantly associated with diagnosis and extent of vascular risk. Regional WMH analyses revealed significant differences in WMH across regions that also differed significantly according to diagnosis. In post-hoc analyses, significant differences were seen between CN and AD in posterior periventricular regions and the splenium of the CC. MCI subjects had intermediate values at all regions. Repeated measures analysis including vascular risk factors in the model found a significant relationship between periventricular WMH and vascular risk that differed by region, but regional differences according to diagnosis remained significant and there was no interaction between diagnosis and vascular risk. CONCLUSIONS: Differences in white matter hyperintensities (WMH) associated with increasing cognitive impairment appear related to both extent and spatial location. Multiple regression analysis of regional WMH, vascular risk factors, and diagnosis suggest that these spatial differences may result from the additive effects of vascular and degenerative injury. Posterior periventricular and corpus callosum extension of WMH associated with mild cognitive impairment and Alzheimer disease indicate involvement of strategic white matter bundles that may contribute to the cognitive deficits seen with these syndromes.
OBJECTIVE: To analyze the extent and spatial distribution of white matter hyperintensities (WMH) in brain regions from cognitively normal older individuals (CN) and patients with mild cognitive impairment (MCI) and Alzheimer disease (AD). METHODS: We studied 26 mild AD, 28 MCI, and 33 CN. MRI analysis included quantification of WMH volume, nonlinear mapping onto a common anatomic image, and spatial localization of each WMH voxel to create an anatomically precise frequency distribution map. Areas of greatest frequency of WMH from the WMH composite map were used to identify 10 anatomic regions involving periventricular areas and the corpus callosum (CC) for group comparisons. RESULTS: Total WMH volumes were associated with age, extent of concurrent vascular risk factors, and diagnosis. After correcting for age, total WMH volumes remained significantly associated with diagnosis and extent of vascular risk. Regional WMH analyses revealed significant differences in WMH across regions that also differed significantly according to diagnosis. In post-hoc analyses, significant differences were seen between CN and AD in posterior periventricular regions and the splenium of the CC. MCI subjects had intermediate values at all regions. Repeated measures analysis including vascular risk factors in the model found a significant relationship between periventricular WMH and vascular risk that differed by region, but regional differences according to diagnosis remained significant and there was no interaction between diagnosis and vascular risk. CONCLUSIONS: Differences in white matter hyperintensities (WMH) associated with increasing cognitive impairment appear related to both extent and spatial location. Multiple regression analysis of regional WMH, vascular risk factors, and diagnosis suggest that these spatial differences may result from the additive effects of vascular and degenerative injury. Posterior periventricular and corpus callosum extension of WMH associated with mild cognitive impairment and Alzheimer disease indicate involvement of strategic white matter bundles that may contribute to the cognitive deficits seen with these syndromes.
Authors: S J Teipel; W Bayer; G E Alexander; A L W Bokde; Y Zebuhr; D Teichberg; F Müller-Spahn; M B Schapiro; H-J Möller; S I Rapoport; H Hampel Journal: Neurobiol Aging Date: 2003 Jan-Feb Impact factor: 4.673
Authors: M Tullberg; E Fletcher; C DeCarli; D Mungas; B R Reed; D J Harvey; M W Weiner; H C Chui; W J Jagust Journal: Neurology Date: 2004-07-27 Impact factor: 9.910
Authors: Merrill F Elias; Lisa M Sullivan; Ralph B D'Agostino; Penelope K Elias; Alexa Beiser; Rhoda Au; Sudha Seshadri; Charles DeCarli; Philip A Wolf Journal: Stroke Date: 2004-01-15 Impact factor: 7.914
Authors: Denise Head; Randy L Buckner; Joshua S Shimony; Laura E Williams; Erbil Akbudak; Thomas E Conturo; Mark McAvoy; John C Morris; Abraham Z Snyder Journal: Cereb Cortex Date: 2004-04 Impact factor: 5.357
Authors: L Gootjes; S J Teipel; Y Zebuhr; R Schwarz; G Leinsinger; P Scheltens; H-J Möller; H Hampel Journal: Dement Geriatr Cogn Disord Date: 2004-06-21 Impact factor: 2.959
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Stroke Date: 2004-06-24 Impact factor: 7.914
Authors: Coreyann Poly; Joseph M Massaro; Sudha Seshadri; Philip A Wolf; Eunyoung Cho; Elizabeth Krall; Paul F Jacques; Rhoda Au Journal: Am J Clin Nutr Date: 2011-11-09 Impact factor: 7.045
Authors: Anne F Wiegman; Irene B Meier; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Adam M Brickman Journal: J Am Geriatr Soc Date: 2013-12 Impact factor: 5.562
Authors: Kayla A Steward; Richard Kennedy; Guray Erus; Ilya M Nasrallah; Virginia G Wadley Journal: Neuropsychologia Date: 2019-05-04 Impact factor: 3.139
Authors: J M Prager; C Thomas; W J Ankenbrandt; J R Meyer; Y Gao; A Ragin; S Sidharthan; R Hutten; Y G Wu Journal: AJNR Am J Neuroradiol Date: 2014-01-16 Impact factor: 3.825
Authors: Noll L Campbell; Fred Unverzagt; Michael A LaMantia; Babar A Khan; Malaz A Boustani Journal: Clin Geriatr Med Date: 2013-11 Impact factor: 3.076
Authors: Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Alzheimers Dement Date: 2016-08-10 Impact factor: 21.566